| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
V43926-5mg |
≥98% | ￥880.00 |
货期：3-5天 | - | - | - | - |
|
V43926-10mg |
≥98% | ￥1480.00 |
货期：3-5天 | - | - | - | - |
|
V43926-25mg |
≥98% | ￥2980.00 |
货期：3-5天 | - | - | - | - |
|
V43926-50mg |
≥98% | ￥4780.00 |
货期：3-5天 | - | - | - | - |
|
V43926-100mg |
≥98% | ￥7670.00 |
货期：3-5天 | - | - | - | - |
|
| 产品描述： | PB2 is a tris(2-carboxyethyl)phosphine (TCEP) analogue increasing retinal ganglion (RGCs) cells survival after axotomy in vitro at nanomolar and picomolar concentrations. PB2 is substantially more permeable than TCEP. PB2, as a reducing agent, is highly neuroprotective for RGCs. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 体外研究： | PB2 (0.001~100000 nM; 72 hours; RGCs) increases RGC viability. PB2 has modifications that neutralize the polarity of the compounds. The methylesters of PB2 is likely to be cleaved by cytosolic esterases, yielding a polar intracellular intermediate that would be unlikely to cross cell membranes. |
||||||||||||||||||||
| 保存条件： | 2-8°C, 氮气保存 | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
